These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 34868713)

  • 21. The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article.
    Shah SB; Pahade A; Chawla R
    J Anaesthesiol Clin Pharmacol; 2020; 36(4):471-476. PubMed ID: 33840926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later.
    Gasnier M; Choucha W; Montani D; Noël N; Verstuyft C; Radiguer F; Monnet X; Becquemont L; Corruble E; Colle R;
    Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):762-767. PubMed ID: 36263650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decomposition mechanism of hydroxychloroquine in aqueous solution by gamma irradiation.
    Boujelbane F; Nasr K; Sadaoui H; Bui HM; Gantri F; Mzoughi N
    Chem Zvesti; 2022; 76(3):1777-1787. PubMed ID: 35106020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application.
    Alvarez JC; Davido B; Moine P; Etting I; Annane D; Larabi IA; Simon N
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxychloroquine Toxicity Management: A Literature Review in COVID-19 Era.
    Bakhsh HT
    J Microsc Ultrastruct; 2020; 8(4):136-140. PubMed ID: 33623735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ecological impact of liquid chromatographic methods reported for bioanalysis of COVID-19 drug, hydroxychloroquine: Insights on greenness assessment.
    Shaaban H
    Microchem J; 2023 Jan; 184():108145. PubMed ID: 36404889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of hydroxychloroquine in blood from SLE patients using LC-HRMS-evaluation of whole blood, plasma, and serum as sample matrices.
    Carlsson H; Hjorton K; Abujrais S; Rönnblom L; Åkerfeldt T; Kultima K
    Arthritis Res Ther; 2020 Jun; 22(1):125. PubMed ID: 32475347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a liquid chromatography tandem mass spectrometry method for the simultaneous determination of hydroxychloroquine and metabolites in human whole blood.
    Austin D; John C; Hunt BJ; Carling RS
    Clin Chem Lab Med; 2020 Sep; 58(12):2047-2061. PubMed ID: 32915766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of an LC-MS/MS method for determination of hydroxychloroquine, its two metabolites, and azithromycin in EDTA-treated human plasma.
    Sok V; Marzan F; Gingrich D; Aweeka F; Huang L
    PLoS One; 2021; 16(3):e0247356. PubMed ID: 33667247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxychloroquine is protective to the heart, not harmful: a systematic review.
    Prodromos CC; Rumschlag T; Perchyk T
    New Microbes New Infect; 2020 Sep; 37():100747. PubMed ID: 32839670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxychloroquine serum concentration in coronavirus disease 2019 (COVID-19) patients: a retrospective study.
    Zohra SF; Nassima L
    Forensic Sci Res; 2021; 6(3):215-217. PubMed ID: 34868713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety.
    Takla M; Jeevaratnam K
    Saudi Pharm J; 2020 Dec; 28(12):1760-1776. PubMed ID: 33204210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
    PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse.
    Morrisette T; Lodise TP; Scheetz MH; Goswami S; Pogue JM; Rybak MJ
    Infect Dis Ther; 2020 Sep; 9(3):561-572. PubMed ID: 32740858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics.
    Martin-Blondel G; Ruiz S; Murris M; Faguer S; Duhalde V; Eyvrard F; Izopet J; Mansuy JM; Rolland Y; Delavigne K; Guimbaud R; Pugnet G; Conil JM; Georges B; Delobel P; Minville V; Silva Sifontes S; Concordet D; Gandia P
    Clin Infect Dis; 2020 Dec; 71(11):2962-2964. PubMed ID: 32392332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychloroquine and COVID-19.
    Sinha N; Balayla G
    Postgrad Med J; 2020 Sep; 96(1139):550-555. PubMed ID: 32295814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does hydroxychloroquine combat COVID-19? A timeline of evidence.
    Alia E; Grant-Kels JM
    J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236
    [No Abstract]   [Full Text] [Related]  

  • 38. Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.
    Perinel S; Launay M; Botelho-Nevers É; Diconne É; Louf-Durier A; Lachand R; Murgier M; Page D; Vermesch R; Thierry G; Delavenne X
    Clin Infect Dis; 2020 Nov; 71(16):2227-2229. PubMed ID: 32255489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxychloroquine: balancing the need to maintain therapeutic levels with ocular safety: an update.
    Abdulaziz N; Shah AR; McCune WJ
    Curr Opin Rheumatol; 2018 May; 30(3):249-255. PubMed ID: 29517495
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.